HelpAcademyLoginJoin us as a Member

Nkarta, Inc.

Sign in to save Nkarta, Inc. to a watchlist Sign in to set an alert for Nkarta, Inc.
Tickers
NKTX
Headquarters
Not recorded
SEC CIK
0001787400
Website
Not recorded

Closing prices

Latest close, 1.66

Closing prices for NKTX249 stored closes for NKTX from 3 Nov 2025 to 29 Oct 2026. Lowest 1.66 on 29 Oct 2026, highest 3.67 on 8 Jul 2026, latest 1.66 on 29 Oct 2026.Close1.002.003.004.003 Nov 20251 May 202629 Oct 2026
249 stored closes, oldest first. End of day, not intraday.

Source: Massive Closing prices as of End-of-day prices, not live

Massive Basic, non-business use; display licence needed before launch (D-1). Marketstack is kept as the backup source.

Not investment advice. End-of-day closing prices, not live quotes.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

No Drugs@FDA application has a sponsor name that matches this company.

Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Latest value of each metric as reported to the SEC
MetricReported valuePeriodFiling
Revenue0 USD 1 Jan 2025 to 31 Dec 2025 FY202510-K for Revenue on sec.gov (opens in a new tab)Filed
Net income (loss)−40,368,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Net income (loss) on sec.gov (opens in a new tab)Filed
Research and development expense29,046,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Research and development expense on sec.gov (opens in a new tab)Filed
Operating expenses43,128,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Operating expenses on sec.gov (opens in a new tab)Filed
Cash and cash equivalents24,958,000 USD At 30 Jun 2026 FY2026 Q210-Q for Cash and cash equivalents on sec.gov (opens in a new tab)Filed
Short-term investments and marketable securities157,806,000 USD At 30 Jun 2026 FY2026 Q210-Q for Short-term investments and marketable securities on sec.gov (opens in a new tab)Filed
Total liabilities89,907,000 USD At 30 Jun 2026 FY2026 Q210-Q for Total liabilities on sec.gov (opens in a new tab)Filed
Stockholders' equity247,738,000 USD At 30 Jun 2026 FY2026 Q210-Q for Stockholders' equity on sec.gov (opens in a new tab)Filed
Common shares outstanding (cover page)71,624,791 shares At 5 Aug 2026 FY2026 Q210-Q for Common shares outstanding (cover page) on sec.gov (opens in a new tab)Filed

History

Revenue, newest period first
PeriodReported valueFiling
1 Jan 2025 to 31 Dec 2025 FY20250 USD10-K filed 25 Mar 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2024 to 31 Dec 2024 FY20240 USD10-K filed 26 Mar 2025 on sec.gov (opens in a new tab)Filed
1 Jan 2019 to 31 Dec 2019 FY2020115,000 USD10-K filed 25 Mar 2021 on sec.gov (opens in a new tab)Filed
1 Apr 2019 to 30 Jun 2019 FY2020 Q22,308 USD10-Q filed 20 Aug 2020 on sec.gov (opens in a new tab)Filed

Values as reported in the company's XBRL filings to the SEC, one per calendar period (SEC frames); not adjusted, not audited by HealthTrade, and not investment advice.

Source: SEC XBRL company facts (opens in a new tab) · Licence: public-domain · as of 2026-10-25 · read

SEC filings

SEC filings from Nkarta, Inc., newest first
FormFiledWhat it coversDocument
10-QEvent 30 Jun 2026 Quarterly report (10-Q) View Quarterly report (10-Q) filed 10 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001787400-26-000017 (opens in a new tab)
8-K Current report (8-K)
  • Results of operations and financial condition (Item 2.02)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 10 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-342402 (opens in a new tab)
4Event 18 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 22 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-277507 (opens in a new tab)
8-KEvent 10 Jun 2026 Current report (8-K)
  • Shareholder vote results (Item 5.07)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 11 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-267830 (opens in a new tab)
4Event 10 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 11 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001231919-26-000621 (opens in a new tab)
4Event 10 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 11 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-267632 (opens in a new tab)
4Event 10 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 11 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-267601 (opens in a new tab)
4Event 10 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 11 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-267538 (opens in a new tab)
4Event 10 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 11 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-267524 (opens in a new tab)
4Event 10 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 11 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-267521 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

All rows for Nkarta, Inc. on Insider Trades

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
None in this period
Other all other codes
None in this period

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.